Toshio Fujiwara

Title: Innovations of Toshio Fujiwara

Introduction

Toshio Fujiwara is a notable inventor based in Paramus, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, one includes "Crystalline substituted pyrazines as PGI2 receptor agonists." This invention aims to provide a novel crystal of 2-{4-[N-{5, 6-diphenylpyrazin-2-yl}-N-isopropylamino]butyloxy}acetic acid, referred to as 'Compound B.' Another significant patent is related to new crystals of (S)-N-[1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N-(pyrazin-2-yl)pyridine-2,6-diamine maleate, known as 'compound A.' This patent describes a Form-I crystal of compound A, which shows specific diffraction peaks in its X-ray powder diffraction spectrum. Additionally, a Form-II crystal of compound A is also detailed, showcasing its unique diffraction characteristics.

Career Highlights

Toshio Fujiwara is currently associated with Nippon Shinyaku Company, Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of pyrazine compounds in medical science.

Collaborations

He collaborates with talented coworkers, including Joanna Bis and Senthil Kumar Kusalakumari Sukumar, who contribute to his research and development efforts.

Conclusion

Toshio Fujiwara's innovative work in the field of pharmaceuticals highlights his commitment to advancing medical science through his inventions. His contributions, particularly in the development of novel crystalline compounds, are paving the way for future therapeutic advancements.